Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene results in increased expression of HBA1 mRNA | increases expression | 16917068
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of HBA1 mRNA | increases expression | 19417177
|
C520092 |
cetilistat |
cetilistat results in decreased expression of HBA1 protein modified form | decreases expression | 19461584
|
C030123 |
coumarin |
coumarin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein] | affects cotreatment|decreases reaction|increases glycosylation | 19647726
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of HBA1 mRNA | affects cotreatment|increases expression | 17404688
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HBA1 mRNA] | affects reaction|decreases expression | 15016801
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of HBA1 mRNA | affects cotreatment|decreases expression | 17183730
|
D007501 |
Iron |
ERAF protein binds to and affects the folding of and affects the stability of [HBA1 protein binds to Iron] | affects binding|affects folding|affects stability | 16901899
|
D008741 |
Methyl Methanesulfonate |
Methyl Methanesulfonate results in increased methylation of HBA1 protein | increases methylation | 15655799
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of HBA1 mRNA | increases expression | 15120970
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased carbamoylation of HBA1 protein | increases carbamoylation | 15655799
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of HBA1 mRNA | affects expression | 15651846
|
C055122 |
orlistat |
orlistat results in decreased expression of HBA1 protein modified form | decreases expression | 19207292 19461584
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of HBA1 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of HBA1 mRNA | increases expression | 17404688
|
C059514 |
resveratrol |
resveratrol binds to and affects the folding of HBA1 protein | affects binding|affects folding | 17597382
|
D013311 |
Streptozocin |
coumarin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein] | affects cotreatment|decreases reaction|increases glycosylation | 19647726
|
D013311 |
Streptozocin |
[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein | affects cotreatment|increases glycosylation | 19647726
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HBA1 mRNA | decreases expression | 16054898
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of HBA1 mRNA | affects cotreatment|decreases expression | 17183730
|
D009536 |
Niacinamide |
coumarin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein] | affects cotreatment|decreases reaction|increases glycosylation | 19647726
|
D009536 |
Niacinamide |
[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein | affects cotreatment|increases glycosylation | 19647726
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.11 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.86 | 19490988 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.79 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.14 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
7.14 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
7.14 | 15688392 15113128 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.28 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.32 | 16835633 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.59 | 16640825 |
MESH:D017085 |
alpha-Thalassemia |
marker/mechanism |
|
| |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
4.54 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.54 | 16162502 16183991 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.18 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
14.55 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Iron |
14.55 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
14.55 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.59 | 16569441 17147795 17375513 17163184 17162259 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.75 | 16910769 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.52 | 17497229 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.31 | 16604332 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.46 | 17115116 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.69 | 10378619 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.39 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
6.93 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.93 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.36 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.36 | 20603192 18177632 17507914 16609825 18558336 18775368 18316065 17688650 18985861 19460635 15238991 18940202 19232924 18396377 17157402 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
5.13 | 16640825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.04 | 20046352 17594078 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.10 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.98 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.88 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.88 | 8888407 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.28 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.19 | 15845082 15665606 15380490 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.22 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.94 | 12948864 17018787 17289903 17261762 19861407 14630087 16675129 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.94 | 15136595 16557594 19217205 16110121 16595493 18608205 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
2.94 | 16253758 11306469 14633655 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.94 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.94 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.94 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.10 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.92 | 17687719 10378619 |
MESH:D019121 |
Burkholderia Infections |
|
orlistat |
6.58 | 17874328 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.40 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.46 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
12.46 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.00 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.00 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.77 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.77 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.77 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
8.77 | 18930000 16332177 17971768 17045692 16799960 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.77 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.53 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.99 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.82 | 16757204 17066447 16280240 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
4.82 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.33 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
4.00 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
3.44 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.43 | 15458977 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
3.95 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.75 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.75 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
15.75 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
15.75 | 2727394 7505956 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
MESH:D054506 |
Chloracne |
marker/mechanism |
|
| 17101203 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D002916 |
Chylothorax |
|
orlistat |
6.58 | 17003701 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 15668235 15340226 8697196 12621046 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.06 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.91 | 15001691 16340194 16510598 17169374 17725105 17016597 17018589 17287894 18772588 17172411 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
5.91 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.91 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.66 | 15289873 15148649 18383874 16391804 14970324 16303861 18949393 16524972 18288408 20501625 17016601 18448328 17255274 18509181 17094418 16282729 17594712 16331619 17454858 17401013 18802399 17695437 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.66 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.71 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.45 | 16575769 17688650 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.68 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.68 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.73 | 16733453 |
MESH:D048909 |
Diabetes Complications |
|
orlistat |
5.78 | 19207292 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
9.64 | 16640825 16604332 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
9.64 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
8.64 | 16873680 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
8.64 | 19960420 6379147 7637645 12644472 19496084 11055810 15862027 11260395 18603373 18715473 16684804 15298345 16286809 12093613 2177838 19586609 12446591 12083368 8740154 17442507 15831366 17874149 19298542 1374869 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
6.06 | 16506275 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
6.06 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
coumarin |
13.54 | 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
13.54 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Niacinamide |
13.54 | 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
13.54 | 19647726 19586609 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
13.54 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.66 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.85 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
14.85 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
14.85 | 19682444 19960420 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.43 | 17187935 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.36 | 17662242 |
MESH:D003967 |
Diarrhea |
|
orlistat |
4.65 | 20002075 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.81 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.81 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.81 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.81 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.71 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.99 | 1851702 |
MESH:D004487 |
Edema |
|
Mustard Gas |
11.19 | 9260866 11402378 11428631 11428647 |
MESH:D004487 |
Edema |
|
resveratrol |
11.19 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.19 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.13 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.13 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.94 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.73 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.73 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.78 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.09 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.86 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.90 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.53 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.23 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.00 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.10 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.43 | 16481741 15173087 17638652 16337965 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Iron |
8.00 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.00 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.83 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.07 | 8888407 18558336 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
5.17 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.89 | 20067830 |
MESH:D005414 |
Flatulence |
|
orlistat |
6.58 | 20002075 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.36 | 16604332 16640825 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
6.29 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
6.29 | 9825942 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.34 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.30 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
4.23 | 12093613 |
OMIM:140700 |
HEINZ BODY ANEMIAS |
marker/mechanism |
|
| |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.44 | 16574947 17255318 16640825 16604332 17053826 17236123 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
5.16 | 16604332 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.41 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.87 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
8.54 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.54 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.98 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.12 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.64 | 16597321 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.70 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.81 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.94 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
orlistat |
9.62 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.62 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.88 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.56 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.24 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.35 | 16640825 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
5.02 | 16640825 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
11.27 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
11.27 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
3.75 | 7193160 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
11.71 | 8975870 11402378 9260866 11428631 17524151 9357497 11428620 11428647 16001271 |
MESH:D007249 |
Inflammation |
|
Progesterone |
11.71 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
11.71 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.71 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.49 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.77 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
orlistat |
7.77 | 17201808 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.97 | 17163184 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.36 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
6.36 | 12093613 |
MESH:C531755 |
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
|
orlistat |
6.58 | 17185156 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.31 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.31 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.31 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.31 | 16985049 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.14 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.53 | 16087638 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.36 | 16563566 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
4.15 | 15526292 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
7.39 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
orlistat |
7.39 | 17404856 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.24 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12878042 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.94 | 16737972 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.00 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
14.00 | 18383874 17045692 16603448 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
14.00 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
14.00 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.00 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.59 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.59 | 12151625 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.40 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.40 | 18702808 18161513 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.21 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.54 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
6.54 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
6.54 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
6.54 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.54 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.73 | 15086387 |
MESH:D008207 |
Lymphatic Metastasis |
|
orlistat |
5.82 | 18770866 20805790 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
3.96 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
10.33 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
10.33 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.81 | 14749477 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.94 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.19 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.98 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
13.98 | 15313902 10838139 11807958 16944150 10767621 17131329 16619500 17020996 15113128 15688392 11751437 19196723 16051031 14633655 16827153 12931682 14999141 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
13.98 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
13.98 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.43 | 19453300 |
MESH:D008545 |
Melanoma |
|
orlistat |
3.97 | 18770866 20805790 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.97 | 17992120 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.31 | 17112576 |
MESH:D008708 |
Methemoglobinemia |
marker/mechanism |
|
| |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.83 | 17671175 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.14 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.58 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.42 | 17164350 17049120 17935668 16490592 14749477 16267019 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.62 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.81 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
orlistat |
5.39 | 18430571 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.96 | 8888407 |
MESH:D009164 |
Mycobacterium Infections |
|
orlistat |
5.44 | 21442799 |
MESH:D009181 |
Mycoses |
|
Iron |
5.41 | 16640825 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.12 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.00 | 16525036 17125593 17188708 17015251 16317513 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
15.05 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
15.05 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
15.05 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.56 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
8.56 | 16604332 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.70 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.14 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.14 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.44 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
8.44 | 15533788 |
MESH:D009369 |
Neoplasms |
|
orlistat |
8.44 | 18710210 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
15.23 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
orlistat |
15.23 | 19381703 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
15.23 | 8985016 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
10.29 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
orlistat |
10.29 | 17012255 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
4.46 | 17178036 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.25 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.08 | 16359493 8888407 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.42 | 11555667 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
8.67 | 17296847 16604332 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.67 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.34 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.39 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.91 | 7688884 16761898 |
MESH:C541083 |
Non-alcoholic Fatty Liver Disease |
|
orlistat |
5.50 | 17404856 |
MESH:D009765 |
Obesity |
|
cetilistat |
6.24 | 19461584 |
MESH:D009765 |
Obesity |
|
orlistat |
6.24 | 16938137 19461584 20002075 21442799 19046740 20540997 19207292 20599501 20065556 21438711 18773755 20518802 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.69 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.69 | 16049721 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.93 | 16640825 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.82 | 16640825 16648989 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.19 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.80 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.80 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.59 | 16929163 15113037 16500647 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
5.59 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
orlistat |
4.78 | 16938137 20065556 |
MESH:D010212 |
Papilloma |
|
Iron |
4.42 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.96 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
3.30 | 16563566 16640825 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Niacinamide |
6.39 | 11026799 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.62 | 16604332 |
MESH:D011041 |
Poisoning |
|
Iron |
8.79 | 16604332 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
8.79 | 15727166 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
orlistat |
5.23 | 17201808 |
MESH:D011087 |
Polycythemia Vera |
marker/mechanism |
|
| |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
10.81 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
10.81 | 18163543 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.37 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
15.93 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.93 | 11118676 11222880 11399792 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
15.93 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.82 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.15 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.15 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.15 | 12376480 15682402 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.15 | 17718901 17636462 15767336 17675339 16731767 17804756 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.96 | 16640825 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.03 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.49 | 12752131 11422049 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.90 | 17720292 17266442 10334151 17894541 17620002 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.95 | 18722050 15538739 16160472 18286688 |
MESH:D012035 |
Refsum Disease |
|
orlistat |
6.01 | 20871815 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.53 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.24 | 16314181 17520802 16317513 17058453 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.50 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
4.36 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.42 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.11 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.83 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.55 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.55 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.55 | 1511512 15475178 11044598 17978042 11738929 16876388 3137016 14763951 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.70 | 12880345 15451306 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
9.41 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
9.41 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.41 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.22 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.73 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.49 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.68 | 19015929 16951190 17522103 18567086 18396642 17498489 16424979 19084572 15786421 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
3.68 | 16257854 15930296 18593901 |
MESH:D013274 |
Stomach Neoplasms |
|
orlistat |
3.68 | 19381703 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.42 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.39 | 16640825 |
MESH:D013789 |
Thalassemia |
marker/mechanism |
|
| |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
5.17 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
3.87 | 7505956 3078959 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.63 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.78 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.78 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.18 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Iron |
4.04 | 16597321 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.46 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
4.93 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
4.93 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.58 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.78 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.78 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.41 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.41 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.07 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
MESH:D014689 |
Venous Insufficiency |
|
coumarin |
5.72 | 12708602 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.24 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |